Tradestie Institutional Equity Comparison Engine

GMGI vs ABUS โ€” Head-to-Head Terminal

6-dimension institutional benchmarking across valuation, multi-year operating margins, normalized momentum, and dealer gamma corridors.

Market Close: 2026-11-20 Buy Verdict Report Ask Alpha

Pillar 1 Executive Scorecard & Category Winner Tally

ABUS Overall Edge

ABUS Captures Institutional Edge (4โ€“0 Pillars ยท 8โ€“2 Matrix Metrics)

Tradestie Institutional Equity Comparison Engine assigns the overall head-to-head edge to Arbutus Biopharma Corporation Common Stock (ABUS) driven by superior Valuation, Growth & Margin, Momentum & Technical, Options & Structure. Fundamentally, GMGI trades at 128.2x Forward P/E with -0.8% operating margin (+15.4% YoY revenue) versus ABUS at 10.2x Forward P/E and 80.1% operating margin (-43.5% YoY). In options structure, GMGI sits in UNCLASSIFIED (N/A IV; Dealer Gamma Walls on Pro) against ABUS sits in CONSOLIDATION (18th %ile IV; Dealer Gamma Walls on Pro).

Valuation Winner ABUS
GMGI 128.2x vs ABUS 10.2x Fwd P/E
Growth & Margin Winner ABUS
Op Margin -0.8% vs 80.1% ยท YoY +15.4% vs -43.5%
Momentum & Technical Winner ABUS
1Y -67.7% vs -5.8% ยท 52W Pos 9% vs 27%
Options & Structure Winner ABUS
UNCLASSIFIED (N/A IV) vs CONSOLIDATION (18th %ile IV)
GMGI NASDAQ
Golden Matrix Group, Inc. Common Stock
Services-Prepackaged Software
$0.64
+9.86% 1D
Market Cap $81.9M
1M Return -7.45%
1Y Return -67.65%
Forward P/E 128.2x
Unified AI Score
51.1 / 100 HOLD
Tech 60.0 Fund 45.0 Flow 50.0 Mom 38.2
ABUS NASDAQ
Arbutus Biopharma Corporation Common Stock
Pharmaceutical Preparations
$4.02
-1.23% 1D
Market Cap $623.9M
1M Return -4.51%
1Y Return -5.85%
Forward P/E 10.2x
Unified AI Score
43.4 / 100 HOLD
Tech 28.0 Fund 48.0 Flow 68.0 Mom 53.7

Pillar 2 Normalized Relative Return Performance (% Indexed to 0%)

1Y Indexed Return: GMGI -67.65% ABUS -5.85% Spread: +33.79 pp (ABUS Lead)

Pillar 3 Operating Profitability Benchmark (Trailing 12-Month)

Split-Invariant Revenue ($B) & Operating Margin (%)
GMGI TTM Op. Margin: -0.8% ABUS TTM Op. Margin: 80.1%
Standardized multi-year USD domestic revenue schedules are unavailable for foreign-domiciled ADR filing schedules on GMGI vs ABUS. Trailing 12-month operating profitability (GMGI -0.8% vs ABUS 80.1%) and valuation multiples (GMGI 128.2x vs ABUS 10.2x Forward P/E) are benchmarked directly in Pillar 4 below.

Pillar 4 Head-to-Head Fundamental & Valuation Matrix

Matrix Tally: GMGI (2) vs ABUS (8)
Institutional Metric GMGI ABUS Criterion Row Winner
Market Capitalization Scale $81.9M $623.9M Larger Scale ABUS
Trailing P/E Ratio Valuation 128.2x 3.6x Lower Multiple ABUS
Forward P/E Ratio Valuation 128.2x 10.2x Lower Multiple ABUS
Revenue Growth (YoY) Growth +15.4% -43.5% Higher Growth GMGI
Operating Margin (TTM) Profitability -0.8% 80.1% Higher Margin ABUS
Net Profit Margin Profitability -3.0% 121.2% Higher Margin ABUS
Return on Equity (ROE) Capital Efficiency -5.0% 269.6% Higher ROE ABUS
52-Week Range Position Momentum 9% ($0โ€“$2) 27% ($4โ€“$5) Stronger Trend ABUS
Beta / 30D Volatility Risk Regime 1.40ฮฒ ยท 117% Vol 1.04ฮฒ ยท 48% Vol Lower Realized Risk ABUS
Unified Institutional Score Composite Signal 51.1 / 100 (HOLD) 43.4 / 100 (HOLD) Higher Composite GMGI

Pillar 5 Options Structure, IV Regime & Dealer Gamma Corridor

Full GMGI vs ABUS Buy Guide
GMGI UNCLASSIFIED
0d in phase ยท OBV NEUTRAL
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile N/A
IV Regime Unclassified
Live GMGI Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →
ABUS CONSOLIDATION
96d in phase ยท OBV ACCUMULATION
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile 18th %ile
IV Regime Compressed (<25th %ile)
Live ABUS Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →

Pillar 6 90-Day Technical & R&D Innovation Disclosures

Corporate R&D & Foundry Tracker
Neither GMGI nor ABUS registered frontier semiconductor/AI engineering publications in the trailing 90-day window; head-to-head edge is anchored on operating margin trajectory, valuation multiples, and options structure above.